Cargando…
Preparation and Characterization of a Novel Chimeric Protein VEGI-CTT in Escherichia coli
Vascular endothelial cell growth inhibitor (VEGI) is a recently identified antiangiogenic cytokine that belongs to the TNF superfamily, and could effectively inhibit endothelial cell proliferation and angiogenesis. Synthetic peptide CTT (CTTHWGFTLC) has been found to suppress invasion and migration...
Autores principales: | Cai, Jiping, Wei, Ruili, Cheng, Jinwei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519132/ https://www.ncbi.nlm.nih.gov/pubmed/18769489 http://dx.doi.org/10.1155/2008/564969 |
Ejemplares similares
-
Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
por: Dong, Xinhuai, et al.
Publicado: (2020) -
CoVEGI: Cooperative Verification via Externally Generated Invariants
por: Haltermann, Jan, et al.
Publicado: (2021) -
Corrigendum: Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
Publicado: (2022) -
VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma
por: Xu, Yinhai, et al.
Publicado: (2021) -
CTT: CNN Meets Transformer for Tracking
por: Yang, Chen, et al.
Publicado: (2022)